Trials / Unknown
UnknownNCT03977545
Actigraphy and Neonatal Abstinence Syndrome
Assessment of Actigraphy in the Management of Neonatal Opioid Abstinence Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- Accepted
Summary
The aim of our study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome.
Detailed description
Neonatal opioid abstinence syndrome occurs after birth when opioids were used by the mother during pregnancy. Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal abstinence syndrome but they are subjective. The majority of items in these scores are motor skills items. Actigraphy allows to measure objectively the newborn motricity. We will analyse the correlation between actigraphy and Lipsitz scoring system in four groups of newborns.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Actigraphy | Actigraphy will be realized twice a day during 30 minutes and Lipsitz scoring system will be realized at the same moment to analyze the correlation between Lipsitz scoring system and actigraphy in each arm. |
Timeline
- Start date
- 2019-01-23
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2019-06-06
- Last updated
- 2021-05-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03977545. Inclusion in this directory is not an endorsement.